The global Parenteral Nutrition Market was valued at $5.34 Billion in 2017 and is forecast to grow at a modest6.6 % CAGR between 2018 and 2025, culminating in 2025 global sales of $ x.xBillion.
Parenteral nutrition is also referred as intravenous feeding is a way to get nutrition into your body through your veins. Parenteral nutrition delivers nutrients such as sugar, carbohydrates, proteins, lipids, electrolytes, and trace elements to the body. These nutrients are vital in maintaining high energy, hydration, and strength levels. Some people only need to get certain types of nutrients intravenously.
Parenteral nutrition can cause some serious side effects such as mouth sores, poor night vision, and skin changes. Apart from this, it can cause changes in heartbeat, confusion, convulsions or seizures, difficulty breathing, fast weight gain or weight loss, fatigue, fever or chills, increased urination, jumpy reflexes, memory loss, muscle twitching, thirst, tingling in your hands or feet, swelling of your hands, feet, or legs, weakness, or cramps, stomach pain, vomiting.
“Optimal Price Point (OPP) for Parenteral Nutrition Products”
Estimated Average product/ service cost – $ xx globally. However, with improving access and availability of options, OPP and range of acceptable Prices (RAP) are going to change. We at Ameri Research continuously track these prices with our proprietary pricing model.
Due to the wide array of products available in the market, pricing, positioning, and sales channel optimization play a vital role in the success of a product. On an average, in the U.S., the Parenteral Nutritionproducts are available at USD xxx- USD xxxx. However, the high-end products are available at much higher prices. The prices in emerging countries and developed countries vary significantly due to the difference in purchasing power and availability of latest products.
Parenteral NutritionMarket by “NutrientType”
We have segmented theParenteral Nutritionmarket by nutrienttype into Carbohydrates, Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins, Minerals. These nutrients should be removed from the refrigerator at least 6 hours before use. For the temporary purpose, physician can prescribe Peripheral Parenteral Nutrition via peripheral intravenous line, not the central line connected to superior vena cava.
We are observing a greater adaptation of vitamins and minerals Parenteral Nutrition in recent past years. All type of Parenteral Nutrition is expected to have increased adaptation during the forecast period. With improved delivery technology, more and more physicians are prescribing parenteral nutrients.
We have segmented the Parenteral Nutrition market by categories into PPN (Partial Parenteral Nutrition), TPN(Total Parenteral Nutrition). Partial parenteral nutrition supplements the oral intake and majority of hospitals provide dextrose or amino acid solutions by this method to their inpatients.
Parenteral Nutrition Market by “Application”
We have segmented the Parenteral Nutritionmarket by the applicationinto Crohn’s Disease, Cancer, Short Bowel Syndrome, Ischemic Bowel Disease.We are observing major usage for Crohn’s Disease and IBS. However, we are expecting the usage for Cancer patient is going to increase during the forecasting period. One of the challenges with parenteral nutrition administration was not having adequate venous access. However, it has been noticed that using subclavian vein cauterization allowed nutrients to be quickly diluted within the central venous system, thereby decreasing the likelihood of thrombotic complications.
North America accounted for the maximum revenue share of over 53% in 2017 due to increased patient number, lifestyle followed by availability of treatment options, better reimbursement plan,and RND. Followed by EU- Top 5 countries contribute $X.6 Billion in 2017 and expected to reach $x.5 Billion by 2023.
With changing lifestyle in developing countries and availability of treatment option, we are observing a rise in patient numbers in developing countries.
“Competitive Landscape”and“Merger & Acquisition Insights”
The key market participants include Baxter International Inc., Otsuka Pharmaceutical Factory Inc., Allergan plc, B. Braun Melsungen AG, Grifols S.A., Hospira, Sichuan Kelun Pharmaceutical Co. Ltd., FreseniusKabi AG, Vifor Pharma, and Aculife Healthcare. The growing investment in research and development is driving the companies to innovate, stay market relevant and retain their share. Moreover, there are several startup companies working on newer technologies, and these companies are considered as strategic assets for merger and acquisition.
Parenteral NutritionMarket by Nutrient Type (Revenue, Million, 2014 – 2025)
- Lipid Emulsion
- Single Dose Amino Acid Solution
- Trace Elements
Parenteral NutritionMarket byCategories Type(Revenue, Million, 2014 – 2025)
- PPN (Partial Parenteral Nutrition)
- TPN(Total Parenteral Nutrition)
Parenteral Nutrition Market by Application Type (Revenue, Million, 2014 – 2025)
- Crohn’s Disease
- Short Bowel Syndrome
- Ischemic Bowel Disease
Parenteral NutritionMarket Regional Outlook (Revenue,USD Million, 2014- 2025)
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- South Africa
- Saudi Arabia
Parenteral Nutrition Market Market, Parenteral Nutrition Market Market Analytics, Parenteral Nutrition Market Market Share, Parenteral Nutrition Market Market Research, Parenteral Nutrition Market Market Forecast, Parenteral Nutrition Market Market Insight, Parenteral Nutrition Market Market Trend, Parenteral Nutrition Market Market Value,Parenteral Nutrition Market Market Size, Parenteral Nutrition Market Market Analysis, Parenteral Nutrition Market Market Survey